Publications Database

Carey T. et al. (2002)

Double-blind placebo-controlled trial of secretin: effects on aberrant behavior in children with autism.

Journal of Autism and Developmental Disorders

32(3), pp. 161-167

Read Abstract (New Window)

Chez M. G. et al. (2000)

Secretin and autism: a two-part clinical investigation.

Journal of Autism and Developmental Disorders

30(2), pp. 87-94

Read Abstract (New Window)

Coniglio S. J. et al. (2001)

A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism.

Journal of Pediatrics

138(5), pp. 649–655.

Coplan J. et al. (2003)

Children with autistic spectrum disorders. II: Parents are unable to distinguish secretin from placebo under double-blind conditions.

Archives of Disease in Childhood

88(9),

Read Full (New Window)

Corbett B. A. , Khan K. , Czapansky-Beilman D. (2001)

A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism.

Clinical Pediatrics

40(6),

Read Abstract (New Window)

Dunn-Geier J. et al. (2000)

Effect of secretin on children with autism: a randomized controlled trial.

Developmental Medicine and Child Neurology

42(12),

Read Abstract (New Window)

Esch B. E. , Carr J. E. (2004)

Secretin as a treatment for autism: a review of the evidence.

Journal of Autism and Developmental Disorders

October, 34(5), pp. 543-556.

Read Abstract (New Window)

Farmer C. A. , Thurm A. , Grant P. J. (2013)

Pharmacotherapy for the core symptoms in autistic disorder: Current status of the research.

Drugs

73(4), pp. 303-314.

Read Abstract (New Window)

Gringras P. (2000)

Practical paediatric psychopharmacological prescribing in autism: the potential and the pitfalls.

Autism

4(3), pp. 229-247

Read Abstract (New Window)

Handen B. L. , Hofkosh D. (2005)

Secretin in children with autistic disorder: A double-blind, placebo-controlled trial.

Journal of Developmental and Physical Disabilities

June, 17(2), pp. 95-106.

Read Abstract (New Window)

Honomichl R. D. et al. (2002)

Secretin and sleep in children with autism.

Child Psychiatry and Human Development

33(2),

Read Full (New Window)

Horvath K. et al. (1998)

Improved social and language skills after secretin administration in patients with autistic spectrum disorders.

Journal of the Association for Academic Minority Physicians

9(1),

Read Abstract (New Window)

Kern J. K. et al. (2002)

Efficacy of porcine secretin in children with autism and pervasive developmental disorder.

Journal of Autism and Developmental Disorders

32(3),

Read Abstract (New Window)

Kern J. K. , Espinoza E. , Trivedi M. H. (2004)

The effectiveness of secretin in the management of autism.

Expert Opinion on Pharmacotherapy

5(2),

Read Abstract (New Window)

Kidd P. M. (2002)

Autism, an extreme challenge to integrative medicine. Part II: medical management.

Alternative Medicine Review

December, 7(6), pp. 472-499

Read Abstract (New Window) Read Full (New Window)

Klaeger D. , McDougle C. J. (2000)

Secretin in autism— a parent’s perspective.

Journal of Autism and Developmental Disorders

30(1), pp. 72-73.

Klein N. , Kemper K. J. (2016)

Integrative approaches to caring for children with autism.

Current Problems in Pediatric and Adolescent Health Care

June, 46(6), pp. 195-201.

Read Abstract (New Window)

Krishnaswami S. , McPheeters M. L. , Veenstra-VanderWeele J. (2011)

A systematic review of secretin for children with autism spectrum disorders.

Pediatrics

127(5), e1322-e1325

Read Abstract (New Window) Read Full (New Window)

Lee Y. J. et al. (2014)

Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder.

Clinical Psychopharmacology and Neuroscience

Read Abstract (New Window) Read Full (New Window)

Levy S. E. et al. (2003)

Children with autistic spectrum disorders. I: comparison of placebo and single dose of human synthetic secretin.

Archives of Disease in Childhood

88(8),

Read Full (New Window)